What are the limitations of the pcos diagnostic criteria rotterdam?

While the pcos diagnostic criteria rotterdam is highly validated, it should not replace clinical judgment. OpiCalc provides the latest evidence-based limitations for the pcos diagnostic criteria rotterdam to ensure safe bedside use and optimal diagnostic accuracy.

How does the pcos diagnostic criteria rotterdam compare to other Endocrinology scores?

The pcos diagnostic criteria rotterdam is a gold-standard diagnostic tool. OpiCalc provides side-by-side clinical guidance to help clinicians choose the most specific evidence-based tool for their patient's presentation.

Is the pcos diagnostic criteria rotterdam free to use?

Yes. OpiCalc provides the pcos diagnostic criteria rotterdam completely ad-free and optimized for mobile bedside use, ensuring you can calculate medical risk swiftly and without distraction.

Evidence-Based Pcos diagnostic criteria rotterdam Scoring

CLINICAL REFERENCE

CLINICAL INSIGHT

When to Use

Evaluating women with irregular menstrual cycles or amenorrhoea.
Investigating clinical signs of hyperandrogenism (acne, hirsutism).
Workup for infertility or recurrent pregnancy loss.
Initial assessment of polycystic morphology on ultrasound.

CLINICAL INSIGHT

How it Works

Rotterdam Criteria (2/3 required)

Oligo- or anovulation (cycles > 35 days or amenorrhoea).
Clinical and/or biochemical hyperandrogenism.
Polycystic ovaries on ultrasound (≥ 12-20 follicles/ovary or volume > 10 cm³).

MANDATORY Exclusions

Thyroid dysfunction (TSH).
Hyperprolactinaemia (Prolactin).
Non-classic Congenital Adrenal Hyperplasia (17-OHP).
Androgen-secreting tumors (Total T > 150 ng/dL).
Cushing's syndrome (if clinical features present).

CLINICAL INSIGHT

Practical Pearls

Ultrasonography Caveat

Modern ultrasound machines (high-frequency) reveal many more follicles. International consensus guidelines now suggest a threshold of ≥ 20 follicles per ovary when using transducers with ≥ 8 MHz frequency.

Management Note

PCOS is a diagnosis of exclusion. Even if a patient meets 2/3 criteria, the diagnosis is invalid if a mimic like NCAH is not ruled out with a morning 17-hydroxyprogesterone level.

CLINICAL INSIGHT

Evidence Base

Primary Source

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group.Hum Reprod2004

When to Use

When to Use

How it Works

Rotterdam Criteria (2/3 required)

MANDATORY Exclusions

Practical Pearls

Ultrasonography Caveat

Management Note

Evidence Base

Primary Source

PCOS Diagnostic Criteria (Rotterdam)

Criteria Not Met

When to Use

When to Use

How it Works

Rotterdam Criteria (2/3 required)

MANDATORY Exclusions

Practical Pearls

Ultrasonography Caveat

Management Note

Evidence Base

Primary Source

PCOS Diagnostic Criteria (Rotterdam)

Criteria Not Met

Clinical Evidence and Methodology

When to Use

When to Use

How it Works

Rotterdam Criteria (2/3 required)

MANDATORY Exclusions

Practical Pearls

Ultrasonography Caveat

Management Note

Evidence Base

Primary Source

PCOS Diagnostic Criteria (Rotterdam)

Criteria Not Met

Clinical Evidence and Methodology

When to Use

When to Use

How it Works

Rotterdam Criteria (2/3 required)

MANDATORY Exclusions

Practical Pearls

Ultrasonography Caveat

Management Note

Evidence Base

Primary Source

PCOS Diagnostic Criteria (Rotterdam)

Criteria Not Met